PL2717897T3 - Kompozycje peptydów i sposoby leczenia urazu płuc, astmy, anafilaksji, obrzęku naczyniowo-ruchowego, układowych zespołów przepuszczalności naczyń i przekrwienia błony śluzowej nosa - Google Patents

Kompozycje peptydów i sposoby leczenia urazu płuc, astmy, anafilaksji, obrzęku naczyniowo-ruchowego, układowych zespołów przepuszczalności naczyń i przekrwienia błony śluzowej nosa

Info

Publication number
PL2717897T3
PL2717897T3 PL12800251T PL12800251T PL2717897T3 PL 2717897 T3 PL2717897 T3 PL 2717897T3 PL 12800251 T PL12800251 T PL 12800251T PL 12800251 T PL12800251 T PL 12800251T PL 2717897 T3 PL2717897 T3 PL 2717897T3
Authority
PL
Poland
Prior art keywords
angioedema
anaphylaxis
asthma
methods
lung injury
Prior art date
Application number
PL12800251T
Other languages
English (en)
Polish (pl)
Inventor
Yulia A. Komarova
Uzma Saqib
Stephen M. Vogel
Asrar B. Malik
Original Assignee
The Board Of Trustees Of The University Of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Board Of Trustees Of The University Of Illinois filed Critical The Board Of Trustees Of The University Of Illinois
Publication of PL2717897T3 publication Critical patent/PL2717897T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL12800251T 2011-06-13 2012-06-13 Kompozycje peptydów i sposoby leczenia urazu płuc, astmy, anafilaksji, obrzęku naczyniowo-ruchowego, układowych zespołów przepuszczalności naczyń i przekrwienia błony śluzowej nosa PL2717897T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161496409P 2011-06-13 2011-06-13

Publications (1)

Publication Number Publication Date
PL2717897T3 true PL2717897T3 (pl) 2017-09-29

Family

ID=47357694

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12800251T PL2717897T3 (pl) 2011-06-13 2012-06-13 Kompozycje peptydów i sposoby leczenia urazu płuc, astmy, anafilaksji, obrzęku naczyniowo-ruchowego, układowych zespołów przepuszczalności naczyń i przekrwienia błony śluzowej nosa

Country Status (15)

Country Link
US (2) US9248198B2 (enExample)
EP (1) EP2717897B1 (enExample)
JP (1) JP6042425B2 (enExample)
KR (1) KR102042015B1 (enExample)
CN (2) CN103608026B (enExample)
AU (1) AU2012271781C1 (enExample)
BR (1) BR112013032108B1 (enExample)
CA (1) CA2838662C (enExample)
DK (1) DK2717897T3 (enExample)
ES (1) ES2633343T3 (enExample)
IL (1) IL229771B (enExample)
MX (1) MX349146B (enExample)
PL (1) PL2717897T3 (enExample)
WO (1) WO2012174028A2 (enExample)
ZA (1) ZA201309161B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2633343T3 (es) * 2011-06-13 2017-09-20 The Board Of Trustees Of The University Of Illionis Composiciones de péptidos y métodos para tratar lesión pulmonar, asma, anafilaxis, angioedema, síndromes de permeabilidad vascular sistémica y congestión nasal
CN107427549B (zh) * 2015-03-02 2022-01-11 伊利诺伊大学受托管理委员会 用于抑制血管生成的肽
CN110128506B (zh) * 2019-05-22 2021-03-30 中国药科大学 一种寡肽及其应用
CN110664990B (zh) * 2019-11-07 2021-03-16 江南大学 一种trpc1肽类分子在制备治疗病毒感染引起的炎症的药物中的应用
TW202204375A (zh) * 2020-04-15 2022-02-01 美商寇峇有限公司 治療冠狀病毒感染之方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US6093740A (en) * 1997-04-30 2000-07-25 Eli Lilly And Company Therapeutic treatment for skin disorders
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
US7368430B2 (en) * 2003-11-06 2008-05-06 Research Development Foundation Selective inhibitors of nuclear factor-κB activation and uses thereof
KR101206843B1 (ko) * 2003-12-03 2012-11-30 와이엠 바이오사이언시즈 오스트레일리아 피티와이 엘티디 튜불린 저해제
AU2006292203A1 (en) * 2005-09-21 2007-03-29 Dask Technologies, Llc Methods and compositions for organ and tissue functionality
KR101399175B1 (ko) * 2006-07-21 2014-06-19 푼다싸웅 지 앙빠루 아 뻬스끼자 두 에스따두 지 싸웅 파울루 - 에피아뻬에에씨뻬 항염증성 및 항알레르기성 시클릭 펩티드
US7585865B2 (en) * 2006-07-21 2009-09-08 The Penn State Research Foundation Protein kinase C zeta inhibition to treat vascular permeability
KR20200075044A (ko) * 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
FR2940032B1 (fr) 2008-12-23 2013-08-09 Seb Sa Panier de cuisson d'aliments et systeme de cuisson correspondant
IT1392567B1 (it) * 2008-12-24 2012-03-09 Bioindustry Park Del Canavese S P A Uso di un peptide derivato da er-alfa per il ripristino della sensibilita' a composti antiestrogenici in cellule di tumore mammario
US20100190691A1 (en) 2009-01-27 2010-07-29 Trojan Technologies, Ltd Delivery of nucleic acids using cell-penetrating peptides
ES2633343T3 (es) * 2011-06-13 2017-09-20 The Board Of Trustees Of The University Of Illionis Composiciones de péptidos y métodos para tratar lesión pulmonar, asma, anafilaxis, angioedema, síndromes de permeabilidad vascular sistémica y congestión nasal

Also Published As

Publication number Publication date
MX349146B (es) 2017-07-14
ES2633343T3 (es) 2017-09-20
US9248198B2 (en) 2016-02-02
IL229771B (en) 2019-07-31
US8912139B2 (en) 2014-12-16
WO2012174028A3 (en) 2013-02-21
DK2717897T3 (en) 2017-07-17
EP2717897B1 (en) 2017-04-19
MX2013014650A (es) 2014-01-24
EP2717897A4 (en) 2015-01-07
BR112013032108A2 (pt) 2016-11-22
EP2717897A2 (en) 2014-04-16
US20140213505A1 (en) 2014-07-31
JP6042425B2 (ja) 2016-12-14
CN106188232B (zh) 2020-01-07
CN103608026B (zh) 2016-08-24
CA2838662A1 (en) 2012-12-20
AU2012271781B2 (en) 2017-02-16
CN103608026A (zh) 2014-02-26
CN106188232A (zh) 2016-12-07
WO2012174028A2 (en) 2012-12-20
ZA201309161B (en) 2015-03-25
AU2012271781A1 (en) 2014-01-09
KR102042015B1 (ko) 2019-11-07
US20140155314A1 (en) 2014-06-05
BR112013032108B1 (pt) 2021-10-26
KR20140056185A (ko) 2014-05-09
CA2838662C (en) 2018-07-24
AU2012271781C1 (en) 2017-09-21
JP2014518211A (ja) 2014-07-28

Similar Documents

Publication Publication Date Title
ZA201400792B (en) Novel piperidono-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
HUE054987T2 (hu) Dohányzó eszköz, és további áramláskeltõ eszközök
HUE060685T2 (hu) Elektromos dohányzóeszköz
IL232226A0 (en) Albumin-binding antibodies and their binding fragments
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
EP2214712A4 (en) COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND PULMONARY DISORDERS
EP2736197A4 (en) METHOD, DEVICE AND SYSTEM FOR PACKET COMPOSITION AND RESEQUENCING
SI2729151T1 (sl) Farmacevtski sestavek, postopki za zdravljenje in njihove uporabe
EP2370136A4 (en) INHALATIVE RELEASE PROCEDURES AND DEVICES
EP2655309A4 (en) METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER
ZA201109492B (en) Compositions comprising finafloxacin and methods for treating ophthalmic,otic,or nasal infections
EP2500054A4 (en) GAS FOG INHALER
AU339359S (en) Respiratory mask and/or components thereof
EP2679264A4 (en) INHALER OF GASEOUS MIST
ZA201309161B (en) Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
PL2484916T3 (pl) Sprężarka odśrodkowa mająca dyfuzor o zmiennej geometrii oraz sposób
GB2505810B (en) Nasal aroma breathing pipe
EP2734149A4 (en) DEVICES AND METHODS FOR BREATHING TREATMENT AFFECTED BY SLEEP DISORDERS
ZA201308248B (en) Pack for cigarettes as well as precut part, material web, and method for the manufacture thereof
EP2626065A4 (en) INHIBITABLE COMPOSITION COMPOSITION FOR THE TREATMENT OF ASTHMA
WO2012048115A3 (en) Polypeptides and their use in treating and limiting respiratory syncytial virus infection
PL2790721T3 (pl) Fragmenty nieacylowanej greliny do zastosowania do leczenia zespołu pradera-williego
EP2831093A4 (en) EGFL7-targeting or binding polypeptides and methods for inhibiting angiogenesis
GB0910212D0 (en) Safety asthma inhaler
FI20110021A0 (fi) Kaasutoiminen savukeperusteinen nikotiini- ja tupakka-aromi-inhalaattori